← Open Payments lookup

SAMANTHA MOLLMAN: Open Payments

NPI 1043612609 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$691 in 31 payments from 14 companies in 2025. Trend: 2023 $171 · 2024 $358 · 2025 $691

Food & beverage: $691
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$172
GENZYME CORPORATION2$97
Eisai Inc.2$70
GlaxoSmithKline, LLC.4$65
Regeneron Healthcare Solutions, Inc.3$62
Novartis Pharmaceuticals Corporation2$47
BioCryst US Sales Co., LLC2$36
Otsuka America Pharmaceutical, Inc.2$35
CSL Behring1$23
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: DUPIXENT, Leqembi, TEZSPIRE, NUCALA, FASENRA, ORLADEYO, REXULTI, Haegarda.

Industry payments across ND — which companies pay providers there.